Metformin's protective effect on brain health emerges in 20-year study

A long-term follow-up of a clinical trial suggests that metformin, a common diabetes medication, may reduce the risk of dementia by about half. The effect was observed over more than two decades, though researchers caution that the result is not definitive. The exact biological reason for the potential benefit remains unknown.